Rhythm Biosciences Limited
Andrea Baumgartner is a seasoned legal and regulatory expert with extensive experience across various sectors, including energy, biosciences, and financial services. Currently serving as Principal Consultant at ENRG Consulting and General Counsel & Company Secretary at Rhythm Biosciences Limited, Andrea's work emphasizes legal, regulatory, and compliance advice. Previous roles include General Counsel at WINconnect, Executive General Manager of Retail & Regulatory Affairs at Investorfirst Limited, and Corporate Strategy Analyst at IWL Ltd / CommSec (CBA). Andrea holds a Master Degree in Legal Practice from The Australian National University and multiple degrees in law and commerce, demonstrating a strong academic foundation complemented by a diverse career trajectory. Currently pursuing a Bachelor of Arts at The University of Queensland, Andrea continues to enrich expertise in Latin Language and Literature and Mathematics.
This person is not in any teams
Rhythm Biosciences Limited
Rhythm Biosciences is an innovative Australian, publicly listed medical diagnostics company, with a focus on delivering simple, affordable blood tests for the accurate detection of cancers, providing physicians with accurate and reliable diagnostic tools. Early detection is critical to improving patient outcomes and reducing the global burden of cancer. ColoSTAT®, Rhythm Bioscience’s first simple blood-based cancer test, designed for the early detection of colorectal cancer, has been developed initially as an alternative screening test for individuals unable to or are unwilling to use currently available screening modalities. Rhythm Biosciences is committed to working with likeminded global partners to achieve commercialisation and distribution of these simple solutions.